As the burden of cancers impacting low and middle-income countries (LMICs) is projected to increase, formation of strategic partnerships between institutions in high-income countries and LMIC institutions may serve to accelerate cancer research, clinical care, and training. As the United States (US) National Cancer Institute (NCI) and its Center for Global Health continue to encourage cancer centers to join its global mission, academic cancer centers in the US have increased their global activities. In 2015, the Helen Diller Family Comprehensive Cancer Center (HDFCCC) at the University of California, San Francisco (UCSF) responded to the call for international partnership in addressing the global cancer burden through the establishment of the Global Cancer Program (GCP) as a priority initiative. In developing the GCP, we galvanized institutional support to foster sustained, bi-directional, equitable, international partnerships in global cancer control. Our focus and intent in disseminating this manuscript is to share experiences and lessons learned from the perspective of a US-based, NCI-designated cancer center and to provide a roadmap for other high-income institutions seeking to strategically broaden their missions and address the complex challenges of global cancer control. Herein, we review the formative evaluation, governance, strategic planning, investments in career development, funding sources, program evaluation, and lessons learned. Reflecting on the evolution of our program during the first five years, we observed in our partners a powerful shift towards locally driven priority setting, reduced dependency, and an increased commitment to research as a path to improve cancer outcomes in resource-constrained settings.

中文翻译：

---

将全球肿瘤学作为国家癌症研究所指定癌症中心内优先举措的路线图

由于影响低收入和中等收入国家 (LMIC) 的癌症负担预计将增加，高收入国家机构与 LMIC 机构之间建立战略伙伴关系可能有助于加速癌症研究、临床护理和培训。随着美国国家癌症研究所 (NCI) 及其全球健康中心继续鼓励癌症中心加入其全球使命，美国的学术癌症中心也增加了其全球活动。2015 年，加州大学旧金山分校 (UCSF) 的海伦迪勒家庭综合癌症中心 (HDFCCC) 响应国际合作的号召，通过建立全球癌症计划 (GCP) 作为解决全球癌症负担的方法。优先倡议。在制定 GCP 的过程中，我们激发了机构支持，以在全球癌症控制领域培育持续、双向、公平的国际伙伴关系。我们传播这份手稿的重点和目的是分享从美国 NCI 指定癌症中心的角度吸取的经验和教训，并为其他寻求战略性扩大其使命并解决复杂问题的高收入机构提供路线图全球癌症控制的挑战。在此，我们回顾了形成性评估、治理、战略规划、职业发展投资、资金来源、项目评估和经验教训。回顾我们项目在前五年的演变，我们观察到我们的合作伙伴向本地驱动的优先事项设定、减少依赖性以及加大对研究的投入作为在资源有限的环境中改善癌症结果的途径的有力转变。